Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

(MedPage Today) — ATLANTA — Oral tebipenem pivoxil (TBP-PI) was non-inferior to IV imipenem-cilastatin (IMI-CIL) for treating complicated urinary tract infections (cUTI), including acute pyelonephritis (AP), according to a phase III trial…

Source link : https://www.medpagetoday.com/meetingcoverage/idweek/118144

Author :

Publish date : 2025-10-25 14:25:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Related Posts

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Who Benefits From the MAHA Anti-Science Push?

Parents urged to vaccinate children as flu cases rise

Home Defibrillators Boost Survival, but Fall Short on Cost-Effectiveness

What Vaccine Was Tied to Longer Cancer Survival?

PFAS Exposure and Brain Development; Food Insecurity and Blood Pressure

ACOG President: Changing Tylenol’s Label Will Drive Baseless Fear

Oral Tebipenem Matched IV Antibiotic for Complicated UTIs in Phase III Trial

Who Benefits From the MAHA Anti-Science Push?

Parents urged to vaccinate children as flu cases rise

Home Defibrillators Boost Survival, but Fall Short on Cost-Effectiveness

Early Natural Menopause Linked to 27% Higher Risk

Categories

Archives